These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35512461)

  • 1. Structure of AcrVIA2 and its binding mechanism to CRISPR-Cas13a.
    Song G; Li X; Wang Z; Dong C; Xie X; Yan X
    Biochem Biophys Res Commun; 2022 Jul; 612():84-90. PubMed ID: 35512461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18.
    Wang X; Li X; Ma Y; He J; Liu X; Yu G; Yin H; Zhang H
    Nucleic Acids Res; 2022 Jan; 50(1):512-521. PubMed ID: 34893860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II anti-CRISPR proteins as a new tool for synthetic biology.
    Zhang Y; Marchisio MA
    RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme.
    Knott GJ; East-Seletsky A; Cofsky JC; Holton JM; Charles E; O'Connell MR; Doudna JA
    Nat Struct Mol Biol; 2017 Oct; 24(10):825-833. PubMed ID: 28892041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
    Liu L; Yin M; Wang M; Wang Y
    Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CRISPR Proteins and Their Application to Control CRISPR Effectors in Mammalian Systems.
    Gebhardt CM; Niopek D
    Methods Mol Biol; 2024; 2774():205-231. PubMed ID: 38441767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and mechanistic insights into the inhibition of type I-F CRISPR-Cas system by anti-CRISPR protein AcrIF23.
    Ren J; Wang H; Yang L; Li F; Wu Y; Luo Z; Chen Z; Zhang Y; Feng Y
    J Biol Chem; 2022 Jul; 298(7):102124. PubMed ID: 35697070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage genome engineering with CRISPR-Cas13a.
    Guan J; Oromí-Bosch A; Mendoza SD; Karambelkar S; Berry JD; Bondy-Denomy J
    Nat Microbiol; 2022 Dec; 7(12):1956-1966. PubMed ID: 36316452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases.
    Wandera KG; Alkhnbashi OS; Bassett HVI; Mitrofanov A; Hauns S; Migur A; Backofen R; Beisel CL
    Mol Cell; 2022 Jul; 82(14):2714-2726.e4. PubMed ID: 35649413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the anti-CRISPR, AcrIIC4.
    Kim GE; Lee SY; Park HH
    Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrIF9 tethers non-sequence specific dsDNA to the CRISPR RNA-guided surveillance complex.
    Hirschi M; Lu WT; Santiago-Frangos A; Wilkinson R; Golden SM; Davidson AR; Lander GC; Wiedenheft B
    Nat Commun; 2020 Jun; 11(1):2730. PubMed ID: 32483187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages.
    Johnson MC; Hille LT; Kleinstiver BP; Meeske AJ; Bondy-Denomy J
    Mol Cell; 2022 Jun; 82(11):2161-2166.e3. PubMed ID: 35623354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems.
    Yin P; Zhang Y; Yang L; Feng Y
    J Mol Biol; 2023 Apr; 435(7):167996. PubMed ID: 36754343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas13a system: A novel tool for molecular diagnostics.
    Zhao L; Qiu M; Li X; Yang J; Li J
    Front Microbiol; 2022; 13():1060947. PubMed ID: 36569102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.